Accelerator™ Drug Development Expert Insights
Connected expertise for every stage of drug development and clinical research
Drug development is complex, with critical decisions at every stage that can influence timelines, risk and long-term success. In this overview video, discover how the Accelerator™ Drug Development solution brings together Thermo Fisher Scientific experts across development, manufacturing, clinical supply and clinical research to help streamline workflows, anticipate challenges and keep your program moving confidently toward every milestone.
Watch the video to see how Accelerator™ Drug Development brings key expertise together around your development goals.
Paul Jorjorian
Vice President, Development and Scientific Solutions
Building a strong foundation in early development
Learn why early planning, scalable CMC strategies and connected decision-making can help reduce downstream risk and position your program for long-term success.
Paul Jorjorian is vice president, development and scientific solutions at Thermo Fisher Scientific, bringing deep technical and operational expertise across biologics, mRNA, viral vectors, and small-molecule APIs. His background spans process and analytical method development, manufacturing, technology transfer, scale-up, and CMC strategy. He leads scientific and technology strategies that connect development with manufacturing execution, accelerating technology transfer, strengthening analytical readiness, and advancing innovative, scalable solutions. His work combines scientific rigor with manufacturing experience to solve complex customer challenges and enable reliable progression from early development through clinical and commercial manufacturing.
Luca Russo
Vice President and General Manager, Steriles EU & APAC
Designing manufacturing for long-term success
Discover how early manufacturing decisions, robust processes and integrated planning can help minimize rework, reduce risk and support a smoother path to commercialization.
Luca Russo is vice president/general manager, steriles EU & APAC at Thermo Fisher Scientific. His perspective connects development strategy with the manufacturing requirements needed to support programs as they progress toward commercialization. He focuses on robust, scalable manufacturing processes, effective technology transfer and early alignment across process development, analytics, manufacturing and clinical requirements.
Patricia Pisano
Senior Manager, Global Client Management
Strengthening clinical supply strategy
See how proactive planning, accurate forecasting and close collaboration can help ensure clinical supplies are ready when and where they’re needed to support trial success.
Patricia Pisano is senior manager, global client management at Thermo Fisher Scientific, supporting customers with clinical supply planning and strategy. Her work brings together manufacturing and clinical considerations to support forecasting, packaging, labeling and distribution needs for clinical trials. She emphasizes early planning and collaboration to help customers anticipate supply requirements and navigate operational and regulatory complexities.
Jeremy Liska
Executive Director, Integrated Project Delivery Lead
Delivering more efficient clinical trial execution
Learn how connected planning across clinical operations, regulatory and supply teams can help streamline study execution and keep trials moving forward.
Jeremy Liska is the executive director, integrated project delivery lead at Thermo Fisher Scientific, focused on connecting the planning and execution required to move clinical trials forward. His work brings together clinical operations, regulatory and supply considerations to align timelines, anticipate execution risks and identify opportunities for greater efficiency from study start-up through enrollment and downstream milestones.
Zubair Khan
Senior Manager, IT Customer Experience
Connecting drug development through digital innovation
Discover how digital technologies, data connectivity and AI-enabled insights support smarter decisions, greater visibility and more coordinated drug development.
Zubair Khan is senior manager, IT customer experience at Thermo Fisher Scientific, focused on the digital technologies that connect teams, data and decisions across drug development and clinical research. His work supports greater visibility and collaboration through integrated digital platforms, data analytics and AI-enabled insights, with an emphasis on responsible AI use, human oversight, governance and informed decision-making.
Shauna Nolan
Director, CMC Portfolio Management
Coordinating the drug development journey
See how integrated program management helps connect teams, improve visibility and proactively manage risk to keep complex development programs on track.
Shauna Nolan is director, CMC portfolio management at Thermo Fisher Scientific, helping connect teams and priorities across manufacturing, clinical research and clinical supply. Her work focuses on integrated program oversight, cross-functional collaboration and proactive risk management, helping teams identify potential impacts early, coordinate mitigation strategies and maintain visibility across critical program milestones.
Discuss your next project with our experts
Let’s work together to reach your drug development and clinical trial goals.